A MAJOR new study identifying a broad range of potential benefits of incremental pharmaceutical innovation for India will be released at the US-India Business Council

Bangalore: In a significant move aimed at making clinical trials on human beings more ethical and transparent, the Drugs Controller of India has ruled for the first time that all clinical trials taking place across the country in all areas of health

Mashelkar report says modified organisms are intellectual property THE expert group on patent law headed by R A Mashelkar has recommended that microbes like bacteria, fungi and virus should be patented if they have been modified. The committee has also said India cannot limit its patents to new chemical substances in pharmaceutical products. The recommendations were submitted to the Union

With 12 out of about 130 drug samples in 2007-08 failing laboratory tests, the quality of drugs for humans and livestock animals supplied in Bhutan is under a cloud of questions.

Bhutan

Responding to the show-cause notices issued by the Sindh Environment Protection Agency (Sepa), a number of industrialists on Wednesday clarified their position with regard to their failure to meet the safe environmental standards, a source in the agency said.

With demand for the antidote to H1N1 infection peaking across the world, the select Indian pharmaceutical companies are ramping up production of Tamiflu or its generic version.

Companies are starting preliminary work on a vaccine for the H1N1 flu, or swine flu, and should begin clinical trials soon, but the new vaccine will not be ready for widespread use until October, United States health officials said. Dr.

Novartis yesterday said it would spend